Liminatus Pharma, Inc. (LIMN)

0.23 -0.01 (-3.73%) USD  |  NASDAQ  |  Feb 26, 14:47
More

Liminatus Pharma Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for LIMN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
CDT Equity, Inc. --
LENZ Therapeutics, Inc. Upgrade
Oruka Therapeutics, Inc. Upgrade
Maze Therapeutics, Inc. Upgrade
MapLight Therapeutics, Inc. Upgrade